Abstract
PP-043 The beneficial effects of the calcium sensitizer levosimendan have previously been demonstrated in patients undergoing coronary surgery (CABG) with left ventricular dysfunction however there are still questions regarding optimal dosing and timing of therapy. The goal of this study was to
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
